Home › Kanser sa Suso › Washington › Tacoma

Pag-aaral pangklinika para sa Kanser sa Suso sa Tacoma, WA

Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Tacoma. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

The Vanguard Study: Testing a New Way to Screen for Cancer

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Madigan Army Medical Center, Tacoma

Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06995898

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Nagre-recruitPhase 3

Northwest Medical Specialties, Tacoma
Providence Regional Cancer System, Lacey · 23 mi ang layo

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Providence Regional Cancer System-Lacey, Lacey · 23 mi ang layo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Nagre-recruitPhase 3

Research Site, Puyallup · 8 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07205822

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Nagre-recruitPhase 2

Northwest Medical Specialties, Puyallup · 8 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07102381

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Nagre-recruitPhase 3

Northwest Medical Specialties, PLLC ( Site 0062), Tacoma

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07060807

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Nagre-recruitPhase 3

Research Site, Tacoma

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06103864

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Nagre-recruitPhase 3

Northwest Medical Specialties, Tacoma
Northwest Medical Specialties, Gig Harbor · 8 mi ang layo
Northwest Medical Specialties, Puyallup · 8 mi ang layo
at 1 pa

Edad 60 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06377852

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Nagre-recruitPhase 3

Northwest Medical Specialties, PLLC ( Site 0067), Tacoma

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06966700

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Nagre-recruit

MultiCare Cancer Institute, Tacoma
Northwest Medical Specialties, PLLC, Puyallup · 8 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Nagre-recruitPhase 3

Clinical Trial Site, Olympia · 26 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07085767

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Nagre-recruitPhase 3

MultiCare Health System, Tacoma

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Nagre-recruitPhase 3

Northwest Medical Specialties, PLLC, Tacoma

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Nagre-recruitPhase 3

MultiCare Cancer Institute - Tacoma, Tacoma
Northwest Medical Specialties PLLC, Tacoma
Vista Oncology, Olympia · 26 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06492616

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Nagre-recruitPhase 3

Northwest Medical Specialties, Tacoma

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3

Providence Regional Cancer System-Lacey, Lacey · 23 mi ang layo

Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Nagre-recruitPhase 1/2

Northwest Medical Specialties, PLLC, Tacoma

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 1, 2026 · NCT05735080

BostonGene and Exigent Genomic INsight Study

Nagre-recruitObservasyonal na pag-aaral

Northwest Medical Specialities, Puyallup · 8 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2025 · NCT06272864

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa Tacoma

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.